Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?
about
Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated From Infected Implants versus Controls?Screening of Escherichia coli species biodiversity reveals new biofilm-associated antiadhesion polysaccharides.The eukaryotic-type serine/threonine protein kinase Stk is required for biofilm formation and virulence in Staphylococcus epidermidis[Management of biofilm-associated infections: what can we expect from recent research on biofilm lifestyles?].Hormone-dependent bacterial growth, persistence and biofilm formation--a pilot study investigating human follicular fluid collected during IVF cyclesIntracellular Staphylococcus aureus: the Trojan horse of recalcitrant chronic rhinosinusitis?Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms preexposed to subinhibitory concentrations of vancomycin.Accumulation-associated protein enhances Staphylococcus epidermidis biofilm formation under dynamic conditions and is required for infection in a rat catheter modelIdentification of the amino acids essential for LytSR-mediated signal transduction in Staphylococcus aureus and their roles in biofilm-specific gene expression.Staphylococcal biofilm disassembly.Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycinThe polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosisGo Forth and Colonize: Dispersal from Clinically Important Microbial Biofilms.The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilmsAntimicrobial photodynamic therapy of S. mutans biofilms attached to relevant dental materials.Deciphering mechanisms of staphylococcal biofilm evasion of host immunity.Detection of Biofilms in Biopsies from Chronic Rhinosinusitis Patients: In Vitro Biofilm Forming Ability and Antimicrobial Susceptibility Testing in Biofilm Mode of Growth of Isolated Bacteria.Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.Versatility of Biofilm Matrix Molecules in Staphylococcus epidermidis Clinical Isolates and Importance of Polysaccharide Intercellular Adhesin Expression during High Shear Stress.Chronic illness associated with mold and mycotoxins: is naso-sinus fungal biofilm the culprit?Toxins-antitoxins: diversity, evolution and function.Dendrimers--revolutionary drugs for infectious diseases.New trends in peptide-based anti-biofilm strategies: a review of recent achievements and bioinformatic approaches.Antibiotic-lock therapy: a clinical viewpoint.Synthesis of β-(1→6)-linked N-acetyl-D-glucosamine oligosaccharide substrates and their hydrolysis by Dispersin B.[The significance of biofilm for the treatment of infections in orthopedic surgery : 2017 Update].Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis.Transfer of plasmid DNA to clinical coagulase-negative staphylococcal pathogens by using a unique bacteriophage.Complete Genome Sequence of Staphylococcus epidermidis 1457.Biofunctionalization of silicone polymers using poly(amidoamine) dendrimers and a mannose derivative for prolonged interference against pathogen colonization.Evaluation of an institutional guideline for the treatment of cerebrospinal fluid shunt-associated infections.Biofilm formation on bone-anchored hearing aids.Evaluation of bacterial adherence and biofilm arrangements as new targets in treatment of chronic rhinosinusitis.Antibacterial Activity of the Non-Cytotoxic Peptide (p-BthTX-I)₂ and Its Serum Degradation Product against Multidrug-Resistant Bacteria.Phytosphingosine Prevents the Formation of Young Salivary Biofilms in vitro.Anti-adherence and bactericidal activity of sphingolipids against Streptococcus mutans.Electron Beam Immobilization of Novel Antimicrobial, Short Peptide Motifs Leads to Membrane Surfaces with Promising Antibacterial Properties.Proteomic profile of dormancy within Staphylococcus epidermidis biofilms using iTRAQ and label-free strategies.pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.Importance of Biofilms in Urinary Tract Infections: New Therapeutic Approaches
P2860
Q33874999-1AC1EBCB-EF60-48D3-B4B4-1348DFD04E03Q33894428-122E6EDD-FFD9-4F62-A47B-CC21D38D2A9BQ34038282-93DDD9CE-7C97-4302-BD70-BFC6341D8CD0Q34393088-ED1D7966-B5C1-4CDC-AEAC-8894E2A362F9Q34506433-295B120D-AD98-4CF8-903F-E7F034493F84Q34592432-4C0720F0-921B-4F28-920F-E1DB6BDF704BQ34597842-E6C1D6F8-7D89-447D-9984-3F060E352EA1Q34889740-4AD7098E-4B73-4DB7-9A17-BBE1B93C6625Q35140792-02292B8C-C3CC-4369-9676-60E5199F5650Q35189445-1F6C42CA-D55C-49B2-BB2C-82EB2309238FQ35535689-20A9B039-7C29-4016-806F-88AF70915BEBQ35688871-56524E24-2610-408A-9E8A-A0DA2F576655Q35927449-79675B6D-9989-4A30-8C6B-B9053D5FC380Q36018792-8F29D89B-F3C2-4C1C-B8A7-E69BC72E944AQ36037490-3C7C2A35-A58C-45BE-A544-3696AEF63E2DQ36158847-83288F3D-942E-4A25-A167-8CB66392D1D1Q36340721-9C531840-D9EF-4974-925D-7BA35AFACD38Q36933039-0EEC63A9-27B3-4E1F-A0FF-5301876ED247Q37340078-75C4BA84-0195-43C0-B2FC-0D47B7F4F8C2Q37576173-BD5D3E9B-89F7-41B4-BFC6-C644A0519344Q37912155-51C6700F-7056-4A4C-BE78-78B1616AA06EQ38023801-A246BB5D-51E5-4404-B7FD-B25A799ADEB7Q38047034-7E2F47F2-0D3F-4D7D-8650-C2D3817E5603Q38168929-7865C1BE-890F-44FB-883E-0DBD6C5709C6Q38335973-C3D9176B-9B20-40E8-81E3-D04252B16D02Q40200018-42D07B87-95BB-4FCA-AC49-EDCACFC31F4AQ40418293-6CF7237A-8E7A-4170-9680-3B303FDA158AQ41524650-09346BA2-D9A5-40C1-92D7-292507C5C26EQ41763706-7C8D36F2-C911-48A5-9261-D75E9C8A0D21Q42725123-C8EFDF6C-F7D3-43EA-91BD-EB4F91851E1DQ43662262-5028D79A-715F-4868-8DBB-8AA3C861F92EQ45022154-D39177F5-90FE-44AF-A3FB-FB2F81A575F8Q46201714-3A024802-0B65-46DD-95EF-DFA748D10F41Q48348342-333330A8-A4A1-4C58-B422-DD6D7811C5C3Q49894689-89A5E405-F633-4E07-99F1-3DEB887A0410Q52661196-33578F4B-0A6F-4673-AFFB-3F3937324495Q52679065-DDB1DDD5-E90F-4D3D-8CE0-DC567ED03091Q53316117-707CC9A5-C030-471F-9F5D-50184DDB8D08Q53549292-CB834FD3-D032-4CD7-B838-2F495EF8EB49Q59042611-EAA539A6-9F41-4151-A20C-B3F2F64FDA5F
P2860
Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections?
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Modality of bacterial growth p ...... t biofilm-mediated infections?
@ast
Modality of bacterial growth p ...... t biofilm-mediated infections?
@en
Modality of bacterial growth p ...... t biofilm-mediated infections?
@nl
type
label
Modality of bacterial growth p ...... t biofilm-mediated infections?
@ast
Modality of bacterial growth p ...... t biofilm-mediated infections?
@en
Modality of bacterial growth p ...... t biofilm-mediated infections?
@nl
prefLabel
Modality of bacterial growth p ...... t biofilm-mediated infections?
@ast
Modality of bacterial growth p ...... t biofilm-mediated infections?
@en
Modality of bacterial growth p ...... t biofilm-mediated infections?
@nl
P2860
P1476
Modality of bacterial growth p ...... t biofilm-mediated infections?
@en
P2093
Paul D Fey
P2860
P304
P356
10.1016/J.MIB.2010.09.007
P577
2010-09-29T00:00:00Z